ULS UL Solutions Inc.

NYSE
$75.14

UL Solutions Misses on Normalized EPS, but Accelerating Organic Growth, Record Margins and a Higher Outlook Tell a Stronger Story

UL Solutions (ULS) reported third-quarter earnings of $0.51 per share on Earnings Whispers' normalized basis, 8.9% below the $0.56 consensus. That is a 6.3% year-over-year gain. Revenue of $823.0 million rose 5.1% and topped the $817.87 million consensus by 0.6%. The miss conflicts with the company's own figures. Its GAAP diluted EPS was $0.53, up 8.2%, and its Adjusted Diluted EPS was $0.62, up 10.7%. Investors will see a headline miss alongside a company-reported beat-and-raise narrative. Beneath that measurement gap, the operating trend clearly improved: organic growth accelerated, margins hit records, and the full-year organic growth outlook moved higher.

The quality of the quarter is better than the normalized miss implies, though some details deserve scrutiny. Organic revenue grew 7.0%. Reported growth was lower because divestitures removed $14 million of revenue. Certification testing, the core volume engine, rose to $248 million from $224 million, roughly 11%. Adjusted EBITDA increased 8.3% to $235 million, and the 28.6% margin expanded 90 basis points despite about 30 basis points of incremental transaction costs. Net income margin also improved, but the release credits lower interest expense and foreign exchange for that gain rather than operations alone. Stock-based compensation climbed to $23 million from $15 million, and the company excludes it from adjusted results. That partly explains why adjusted figures look cleaner than GAAP or normalized measures. Cash generation was a clear strength: nine-month free cash flow rose 24.6% to $395 million, even as capital spending jumped to $199 million from $139 million.

The call showed momentum building across the year. Organic growth went from 5.7% in the fourth quarter of 2025 and the first quarter, to 6.6% in the second, to 7.0% now. That is the strongest pace in six quarters. Industrial led with 8.4% organic growth, about 9% excluding advisory, up from 7.2% in the second quarter, and a record 36.1% segment margin. Consumer posted a record 21.4% margin. Its organic growth eased slightly to 5.9% from 6.2%, including roughly 150 basis points of drag from business exits. Management said orders in the energy-transition and materials businesses are growing faster than revenue, which supports demand visibility. Data-center tailwinds persisted, and the company launched three AI data center certification programs covering power distribution, power conversion and liquid cooling. Management's tone was notably more confident, describing the company as "a growth story."

There were blemishes. Risk & Compliance Software posted a $3 million operating loss. Its adjusted EBITDA margin collapsed to 18.9% from 29.7% a year ago and 23.1% in the second quarter, a result management called disappointing. Advisory was roughly flat amid U.S. renewables and commercial real estate headwinds. Transaction and integration costs are also climbing:

  • Full-year 2026 costs are now expected at $37–40 million, about 120 basis points of revenue versus roughly 30 basis points in 2025.
  • Fourth-quarter integration costs are running above earlier expectations.
  • More integration costs are expected in 2027.

The raised organic growth outlook of about 6.5% already absorbs roughly 70 basis points of drag from business exits. The reaffirmed full-year adjusted EBITDA margin of about 27.0% is slightly below the 27.2% year-to-date margin. That suggests a softer fourth quarter as E&E costs and dilution arrive.

The forward story now centers on portfolio reshaping. The $686 million Eurofins E&E acquisition, the largest in company history, closed October 1. It should add about $50 million of fourth-quarter revenue, with back-office integration in 2027 and lab and go-to-market synergies targeted by the end of 2028. The DQS stake sale brought in about $117 million and an expected pre-tax gain of roughly $93 million, which will be excluded from adjusted measures. Proceeds helped cut debt from $766 million at quarter end to $689 million by October 30. That is still well above the $303 million cited for the second quarter. Bears also have regulatory ammunition: the FCC voted to bar Chinese labs from testing electronics for U.S. market authorization. China represented about 25% of 2025 revenue, according to the call, though management expects no material impact.

The market had been skeptical heading into the report. Shares stood at $75.14, down 13.6% since the open after the August report and about 9% below the 200-day moving average. The stock hit a 52-week low of $63.17 in mid-September and has since recovered 18.9% from that level. It remains 15.5% below the inter-earnings high set the day of the last report. Investor sentiment stayed negative and weakened modestly, from -0.10 to -0.16. Apart from the negative price trend, Earnings Whispers trend readings lean positive, consistent with the improving sequential growth picture.

The bottom line is that ULS delivered a better operating quarter than its normalized EPS miss suggests. It posted accelerating organic growth, record segment margins, strong cash flow and a higher organic growth outlook. The concerns are real but specific: rising integration costs, a deteriorating software segment, higher leverage and China regulatory noise. Whether skeptical investors re-engage likely depends on how cleanly E&E is absorbed and whether the measurement gap between normalized and adjusted earnings narrows.

← Back to ULS news

Read our preview of this report →